Atossa Genetics to Present at the Sidoti Semi-Annual Microcap Conference
May 20, 2013 08:00 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - May 20, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), the Breast Health Company™, today announced that Dr. Steven Quay, chairman, CEO and president, will be...
Atossa Genetics Signs Distribution Agreement With Millennium HealthCare
May 02, 2013 09:00 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - May 2, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, has signed an agreement with Millennium HealthCare Inc. (PINKSHEETS: MHCC) for the...
Atossa Genetics: New Recommendations for Preventive Drug Treatment for Breast Cancer Are Helpful but Incomplete
April 23, 2013 10:00 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Apr 23, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, believes that new recommendations published on April 16 by the U.S. Preventative...
Atossa Genetics to Present at FSX San Francisco Investor Conference
April 23, 2013 08:00 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Apr 23, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, announced today that Kyle Guse, CFO and General Counsel, will present the...
Atossa Genetics, Inc. to Present at NINE 2013 - Noble Financial Capital Markets' Ninth Annual Equity Conference
January 18, 2013 08:33 ET
|
Atossa Genetics
SEATTLE, WA--(Marketwire - Jan 18, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS) announced today that Kyle Guse, chief financial officer, general counsel and secretary, will present at the NINE...
Atossa Genetics to Present at OneMedForum and Biotech Showcase
January 03, 2013 08:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - Jan 3, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS) announced today that Dr. Steven C. Quay, M.D., Ph.D., FCAP, Chairman, CEO and President, will present at the...
Atossa Genetics Announces Third Quarter 2012 Financial Results
December 20, 2012 16:01 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - Dec 20, 2012) - Atossa Genetics, Inc. (NASDAQ: ATOS) today announced financial results for the third quarter of 2012, ended September 30, 2012.
"During the...